Follow POL on Twitter The state had reportedly been demanding $200 million but will settle for $15 million. Note that coverage in places like the NYT and AP characterize the suit as being over money spent by the state on alleged side effects; as readers of this site (and Beck & Herrmann) know, there were some other reasons the dollar figures under dispute got so big.
Lilly, Alaska settle Zyprexa suit
Related Entries:
- California rejects tertiary asbestos liability in O'Neill v. Crane
- First Circuit upholds $1.5M table-saw verdict
- Liability for thee, but not for me
- Texas Supreme Court finishes off Garza v. Merck
- Around the web, August 26
- New York judges more likely to acquit than juries
- Around the web, July 12
- Insurers and Toyota sudden acceleration
- What media bias?
- Around the web, June 16
- Somin on federalism and tort reform
- Around the web, May 23
- Gameshow justice: Godwin v. Electrolux Home Prods.
- Refutation of Toyota sudden acceleration hysteria doesn't stop Toyota sudden acceleration litigation
- Viscusi: "Does Product Liability Make Us Safer?"
 |
| Isaac Gorodetski Project Manager, Center for Legal Policy at the Manhattan Institute igorodetski@manhattan-institute.org |
 |
| Bridget Carroll Press Officer, Manhattan Institute bcarroll@manhattan-institute.org |
